Catalyst Wire Dossier Catalyst Wire Dossier

Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (Adults and Adolescents)

Absorbed acellular pertussis-diphtheria-tetanus vaccine (two-component) · Changchun BCHT Biotechnology Co.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (Adults and Adolescents), covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) [Phase 1]

See pricing